https://therapeutics.canurta.com/blogRSS for NodeWed, 28 Oct 2026 03:09:09 GMThttps://therapeutics.canurta.com/post/august-letter-from-the-ceo6a7a2d57feb46c46053218c4Tue, 11 Aug 2026 13:35:04 GMTAkeem Gardnerhttps://therapeutics.canurta.com/post/new-study-shows-hemp-polyphenol-extract-may-protect-cartilage6a733bce5d7bc426a54a1da9Wed, 05 Aug 2026 14:30:06 GMTCanurtahttps://therapeutics.canurta.com/post/polykye-formulations-launch-sovereign-2026-concludes-and-new-research-published6a73be65421979b2d96c018bTue, 02 Jun 2026 04:00:00 GMTCanurtahttps://therapeutics.canurta.com/post/canurta-naturals-launches-hemp-flavonoid-complex-sovereign-2026-sells-out-and-new-scientific-pape6a73b90e83bd56b51ff21cf8Wed, 06 May 2026 04:00:00 GMTCanurtahttps://therapeutics.canurta.com/post/registration-opens-for-sovereign-2026-new-partnership-opportunities-with-canurta-naturals-and-cont6a73b34d71634c518081c31cWed, 08 Apr 2026 04:00:00 GMTCanurtahttps://therapeutics.canurta.com/post/preprint-study-examines-transcriptomic-effects-of-cnr-401-and-cannflavin-a-in-an-als-model69b4498b0d1c152c6e6d5d60Fri, 13 Mar 2026 18:30:14 GMTCanurtahttps://therapeutics.canurta.com/post/canurta-expands-global-reach-with-extractx-partnership-strategic-mou-and-continued-biosynthesis-va6a73ad1871634c518081b4bfTue, 03 Mar 2026 05:00:00 GMTCanurtahttps://therapeutics.canurta.com/post/preclinical-study-evaluates-cannflavins-a-and-b-in-glioblastoma-cell-models699f2c7112cb2e7c18f05924Mon, 02 Mar 2026 16:03:54 GMTCanurtahttps://therapeutics.canurta.com/post/canurta-therapeutics-partners-with-extractx-to-integrate-proprietary-extraction-expertise-into-enhan698f622e460b9174760e62f7Tue, 17 Feb 2026 17:56:59 GMTCanurtahttps://therapeutics.canurta.com/post/canurta-inc-announces-strategic-mou-with-international-business-university-and-iptp-to-advance-comm6973a19477221e862dd69b96Thu, 05 Feb 2026 14:45:05 GMTCanurtahttps://therapeutics.canurta.com/post/canurta-completes-first-tranche-with-phrx-expands-u-s-operations-and-advances-biosynthesis-scale6a73a69f421979b2d96bc3e5Tue, 03 Feb 2026 05:00:00 GMTCanurtahttps://therapeutics.canurta.com/post/canurta-naturals-to-lead-operational-transition-at-fsoil-facility-expanding-cgmp-botanical-extracti69655d5bd1d562b302fcdb55Tue, 27 Jan 2026 22:46:23 GMTCanurtahttps://therapeutics.canurta.com/post/cannflavin-b-as-a-potential-therapeutic-in-autism-related-neurology-restoring-brain-networks-and-re696182108171120a0b1f4754Wed, 14 Jan 2026 14:09:09 GMTCanurtahttps://therapeutics.canurta.com/post/canurta-announces-completion-of-first-tranche-in-strategic-transaction-with-pharmadrug-inc695c0e6a7d25e886c5332081Tue, 06 Jan 2026 13:00:34 GMTCanurtahttps://therapeutics.canurta.com/post/unlocking-the-therapeutic-potential-of-nature-s-rarest-small-molecules6a73817683bd56b51ff18d40Tue, 30 Dec 2025 05:00:00 GMTCanurtahttps://therapeutics.canurta.com/post/strategic-mergers-and-upcoming-cnr-401-research-showcase-at-als-mnd-symposium69543083815d1c9fc763e062Fri, 28 Nov 2025 05:00:00 GMTCanurtahttps://therapeutics.canurta.com/post/canurta-therapeutics-enters-definitive-agreement-with-pharmadrug-inc-to-accelerate-strategic-growth6903d16d85a75737869d88c1Fri, 31 Oct 2025 14:35:11 GMTCanurtahttps://therapeutics.canurta.com/post/canurta-finalizes-phrx-agreement-publishes-als-and-antifungal-research-and-expands-global-ip-portf6913a5e13bacd19aa14952dcFri, 31 Oct 2025 04:00:00 GMTCanurtahttps://therapeutics.canurta.com/post/canurta-launches-satoshi-trials-advances-cnr-401-and-expands-public-market-strategy68e92e5ee9350473cef9dc54Wed, 08 Oct 2025 04:00:00 GMTCanurtahttps://therapeutics.canurta.com/post/canurta-signs-phrx-loi-expands-pipeline-and-advances-ai-platform-development68e92c554bab99a0463cc380Fri, 01 Aug 2025 04:00:00 GMTCanurta